These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 37637796)

  • 1. Racial and ethnic disparities in COVID-19 booster vaccination among U.S. older adults differ by geographic region and Medicare enrollment.
    Hayes KN; Harris DA; Zullo AR; Chachlani P; Wen KJ; Smith-Ray RL; Djibo DA; McCarthy EP; Pralea A; Singh TG; McMahill-Walraven C; Taitel MS; Deng Y; Gravenstein S; Mor V
    Front Public Health; 2023; 11():1243958. PubMed ID: 37637796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults.
    Harris DA; Hayes KN; Zullo AR; Mor V; Chachlani P; Deng Y; McCarthy EP; Djibo DA; McMahill-Walraven CN; Gravenstein S
    JAMA Netw Open; 2023 Aug; 6(8):e2326852. PubMed ID: 37531110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.
    Shoaibi A; Lloyd PC; Wong HL; Clarke TC; Chillarige Y; Do R; Hu M; Jiao Y; Kwist A; Lindaas A; Matuska K; McEvoy R; Ondari M; Parulekar S; Shi X; Wang J; Lu Y; Obidi J; Zhou CK; Kelman JA; Forshee RA; Anderson SA
    Vaccine; 2023 Jul; 41(32):4666-4678. PubMed ID: 37344261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/ethnic and nativity disparities in U.S. Covid-19 vaccination hesitancy during vaccine rollout and factors that explain them.
    Frisco ML; Van Hook J; Thomas KJA
    Soc Sci Med; 2022 Aug; 307():115183. PubMed ID: 35843179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and ethnic and income disparities in COVID-19 vaccination among Medicare beneficiaries.
    Cheng Z; Li Y
    J Am Geriatr Soc; 2022 Sep; 70(9):2638-2645. PubMed ID: 35639044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Variation in COVID-19 Vaccination Uptake Among Medicare Beneficiaries with Cancer History.
    Poghosyan H; Dinan MA; Tamamyan G; Nelson L; Jeon S
    J Racial Ethn Health Disparities; 2023 Oct; 10(5):2354-2362. PubMed ID: 36149576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.
    Bor J; Assoumou SA; Lane K; Diaz Y; Ojikutu BO; Raifman J; Levy JI
    PLoS Med; 2023 Jan; 20(1):e1004167. PubMed ID: 36719864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System.
    Tartof SY; Slezak JM; Puzniak L; Hong V; Frankland TB; Xie F; Ackerson BK; Takhar H; Ogun OA; Simmons S; Zamparo JM; Tseng HF; Jodar L; McLaughlin JM
    JAMA Netw Open; 2023 Jan; 6(1):e2251833. PubMed ID: 36662525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic, Occupational, and Sociodemographic Variations in Uptake of COVID-19 Booster Doses Among Fully Vaccinated US Adults, December 1, 2021, to January 10, 2022.
    Agaku IT; Adeoye C; Long TG
    JAMA Netw Open; 2022 Aug; 5(8):e2227680. PubMed ID: 35984657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: A population-level analysis in St. Louis and Kansas City, Missouri.
    Mody A; Bradley C; Redkar S; Fox B; Eshun-Wilson I; Hlatshwayo MG; Trolard A; Tram KH; Filiatreau LM; Thomas F; Haslam M; Turabelidze G; Sanders-Thompson V; Powderly WG; Geng EH
    PLoS Med; 2022 Aug; 19(8):e1004048. PubMed ID: 36026527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
    Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
    JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic disparities in benefits eligibility and spending among adults on the autism spectrum: A cohort study using the Medicare Medicaid Linked Enrollees Analytic Data Source.
    Benevides TW; Carretta HJ; Rust G; Shea L
    PLoS One; 2021; 16(5):e0251353. PubMed ID: 34032811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Ethnic Disparities in Health Care Use and Access Associated With Loss of Medicaid Supplemental Insurance Eligibility Above the Federal Poverty Level.
    Roberts ET; Kwon Y; Hames AG; McWilliams JM; Ayanian JZ; Tipirneni R
    JAMA Intern Med; 2023 Jun; 183(6):534-543. PubMed ID: 37036727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic Variation in Racial Disparities in Receipt of High-Dose Influenza Vaccine Among US Older Adults.
    Silva JBB; Howe CJ; Jackson JW; Riester MR; Bardenheier BH; Xu L; Puckrein G; van Aalst R; Loiacono MM; Zullo AR
    J Racial Ethn Health Disparities; 2024 Jun; 11(3):1520-1529. PubMed ID: 37184814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era.
    Ioannou GN; Bohnert ASB; O'Hare AM; Boyko EJ; Maciejewski ML; Smith VA; Bowling CB; Viglianti E; Iwashyna TJ; Hynes DM; Berry K;
    Ann Intern Med; 2022 Dec; 175(12):1693-1706. PubMed ID: 36215715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data resource profile: COVid VAXines effects on the aged (COVVAXAGE).
    Hayes KN; Harris DA; Zullo AR; Djibo DA; Smith-Ray RL; Taitel MS; Singh TG; McMahill-Walraven C; Chachlani P; Wen KJ; McCarthy EP; Gravenstein S; McCurdy S; Baird KE; Moran D; Fenson D; Deng Y; Mor V
    Int J Popul Data Sci; 2023; 8(6):2170. PubMed ID: 38425722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months.
    Low EV; Tok PSK; Husin M; Suah JL; Tng BH; Thevananthan T; Appannan MR; Yahaya H; Mohd Zin S; Muhamad Zin F; Sivasampu S; Peariasamy KM
    JAMA Netw Open; 2022 Aug; 5(8):e2226046. PubMed ID: 35947381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
    Andersson NW; Thiesson EM; Laursen MV; Mogensen SH; Kjær J; Hviid A
    BMJ; 2022 Jul; 378():e070483. PubMed ID: 35831006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.